Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $18.5K | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | AwardD (derivative) | $6.7K | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $29K | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | AwardD (derivative) | $20K | Unusual size | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | AwardD (derivative) | $6.7K | Unusual size | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Buy | $17K | conv 87ClusterFirst in 12mo | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | AwardD (derivative) | $562.5K | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | AwardD (derivative) | $675K | SEC | ||
ELITE PHARMACEUTICALS INC /NV/Listing on record | AwardD (derivative) | $450K | SEC |